Before you can access ASH's online program, you must agree to the following:
Last updated January 16, 2009. Please note that this site represents the latest program changes
and differs from the print version in some details.

202.P1.12 Immunodeficiency, Including HIV and Other Infections Poster I

Saturday, December 6, 2008: 5:30 PM-7:30 PM
Hall A (Moscone Center)
Inhibition of HIV-1 by Ferroprotin Expression

Sergei Nekhai, PhD*, Altreisha Foster*, Min Xu, MD*, Xiaomei Niu, MD*, Jamie Rotimi* and Victor R. Gordeuk, MD

Center for Sickle Cell Disease, Howard University, Washington, DC

Mannose-Binding Lectin Deficiency - a Risk Factor for Invasive Aspergillosis in Immunocompromised Patients

Jonathan Lambourne, MD, BA, MRCP1*, Dan Agranoff, PhD, FRCP2*, Aby Buchbinder, MD3, Peter F Troke, PhD4*, Raoul Herbrecht, MD5, Jodi Lindsay, BSc, MSc, PhD1* and Thomas Harrison, MD, MPH, FRCP1*

1Centre for Infection, Division of Cellular & Molecular Medicine, St George's University London, London, United Kingdom
2Department of Infectious Diseases & Immunity, Imperial College London, London, United Kingdom
3Enzon Pharmaceuticals Inc., Bridgewater, NJ
4Global Research & Development, Pfizer Inc. (Retired), Sandwich, United Kingdom
5Oncology and Hematology, Hopital de Hautepierre, Strasbourg Cedex, France

VEBEP Regimen and Highly Active Antiretroviral Therapy (HAART) in Patients (pts) with HD and HIV Infection (HD-HIV): Final Results of the Italian Cooperative Group on AIDS and Tumors (GICAT) Study

Michele Spina, MD1, Andrea Antinori2*, Valentina Neri2*, Giuseppe Rossi3*, Alessandro Re3*, Bernardino Allione4*, Emanuela Chimienti1*, Renato Talamini5* and Umberto Tirelli1*

1Medical Oncology, Centro di Riferimento Oncologico, Istituto Nazionale Tumori, IRCCS, Aviano, Italy
2Ospedale L. Spallanzani, Roma, Italy
3Department of Hematology, Spedali Civili, Brescia, Italy
4Ospedale Civile, Alessandria, Italy
5Epidemiology and Biostatistics, Centro di Riferimento Oncologico, Istituto Nazionale Tumori, IRCCS, Aviano, Italy

Long-Term Follow-up of Rituximab and Infusional Cyclophosphamide, Doxorubicin, and Etoposide (cde) in Combination with HAART in HIV-Related Non-Hodgkin's Lymphomas (NHL)

Michele Spina, MD1, Cecilia Simonelli1*, Emanuela Vaccher1*, Ulrich Jaeger, MD2, Joseph Sparano, MD3, Renato Talamini4* and Umberto Tirelli1*

1Medical Oncology, Centro di Riferimento Oncologico, Istituto Nazionale Tumori, IRCCS, Aviano, Italy
2Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
3Montefiore Medical Center, Albert Einstein Cancer Center, Bronx, NY
4Epidemiology and Biostatistics, Centro di Riferimento Oncologico, Istituto Nazionale Tumori, IRCCS, Aviano, Italy

Rapid Detection of Invasive Fungal Infections in Hemato-Oncological Patients

Christine Landlinger1*, Lenka Baskova1*, Sandra Preuner1*, Martine Van Grotel, MD2, Nico G. Hartwig2*, Marry M. van den Heuvel-Eibrink2* and Thomas Lion1*

1Division of Molecular Microbiology and Development of Genetic Diagnostics, Children's Cancer Research Institute, Vienna, Austria, Vienna, Austria
2Ped. Onc., Eramus MC - Sophia Children's Hosp., Rotterdam, ZH, Netherlands

A New Risk Score for Invasive Aspergillosis in Patients with Haematological Malignancies

Marta Stanzani1*, Mauro Fiacchini2*, Fabio Tumietto3*, Pierluigi Viale4*, Michele Baccarani5 and Nicola Vianelli2*

1Hematology, Institute of Haematology and Clinical Oncology “Lorenzo e Ariosto Serągnoli”, Sant'Orsola-Malpighi Hospital, University of Bolog, Bologna, Italy
2Hematology, Hematology, Institute of Haematology and Clinical Oncology “Lorenzo e Ariosto Serągnoli”, Sant'Orsola-Malpighi Hospital, Bologna, Italy
3Hematology, Division of Infectious Diseases, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
4Clinic of Infectious Diseases, Department of Medical and Morphological Research, Medical School, University of Udine, Clinic of Infectious Diseases, Department of Medical and Morphological Research, Medical School, University of Udine, Udine, Italy
5Department of Hematology and Oncological Sciences, University of Bologna, Bologna, Italy

Immunological Function against Human T-Lymphotrophic Virus Type I in Carriers with Collagen Diseases and HAM/TSP

Tomohiro Kozako, PhD1*, Makoto Yoshimitsu, MD2, Masaki Akimoto, MD, PhD2*, Kakushi Matsushita, MD, PhD2*, Yohann White, MD3*, Shingo Toji4*, Shuji Izumo, MD, PhD3*, Shunro Sonoda, MD, PhD5* and Naomichi Arima, MD, PhD3

1Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan
2Hem. and Immunology, Kagoshima University Hosp., Kagoshima, Japan
3Center for Chronic Viral Diseases, Kagoshima University, Kagoshima, Japan
4Medical and Biological Laboratories, Nagoya, Japan
5Kagoshima University, Kagoshima, Japan

WIP Is a Chaperone for Wiskott-Aldrich Syndrome Protein

Yoji Sasahara1, Miguel A de la Fuente2*, Narayanaswamy Ramesh2*, Shigeru Tsuchiya1* and Raif S Geha2*

1Department of Pediatrics, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
2Division of Immunology, Department of Pediatrics, Children's Hospital Boston, Harvard Medical School, Boston, MA

Infections with Multi-Drug Resistant Gram-Negative Pathogens in Patients Receiving Treatment for Hematological Malignancies: Risk Factors and Outcomes

Hong Yen Ng, B.Sc(Pharm)(Hons), BCOP1*, Gee Chuan Wong, MBBS, MRCP, FRCP2, Vin Cci Ng, B.Sc(Pharm)(Hons)1*, Mun Yee Tham, B.Sc(Pharm)(Hons)1*, Rachel Ong, B.Sc(Pharm)(Hons)1* and Ching Hui Lim, B.Sc(Pharm), BCOP1*

1Pharmacy, Singapore General Hospital, Singapore, Singapore
2Hematology, Singapore General Hospital, Singapore, Singapore

Novel Heterozygous Mutation 572insA in TACI Identified in a Patient with Selective IgA Deficiency

Satoshi Okada, MD, PhD1*, Teruyuki Kajiume, MD, PhD1*, Miyuki Tsumura, MSc1*, Kenichiro Shirao, MD1*, Yoshinori Ohno, MSc2*, Shin'ichiro Yasunaga, MD, PhD2*, Motoaki Ohtsubo, PhD2*, Mostafa Mofamed Sira3*, Hirokazu Kanegane, MD, PhD3*, Toshio Miyawaki, MD, PhD3*, Yoshihiro Takihara, MD, PhD2 and Masao Kobayashi, MD, PhD1

1Pediatrics, Hiroshima University, Hiroshima, Japan
2Dept. of Stem Cell Biology, Hiroshima University, Hiroshima, Japan
3Pediatrics, University of Toyama, Toyama, Japan

In Vivo Genetic Mutations Define Predominant Functions of the Human T-Cell Leukemia/Lymphoma Virus p12I Protein

Genoveffa Franchini, MD1, Risaku Fukumoto1*, Vibeke Andresen1*, Izabela Bialuk1*, Valentina Cecchinato1*, Jean Claude Walser2*, Valerio William Valeri1*, Julie M Nauroth3*, Antoine Gessain4* and Christophe Nicot1*

1Animal Models & Ret. Vaccines, NIH, Bethesda, MD
2Section on Genomic Structure & Function, Laboratory of Molecular & Cellular Biology, Bethesda, MD
3Martek Biosciences Corporation, Columbia, MD
4Unite d'Epidemiologie et Physiopathologie des Virus Oncogenes, Paris, France

Daptomycin Use in Neutropenic Patients with Gram-Positive Bacteremia

Kenneth VI Rolston, MD1*, Scott A McConnell, PharmD2*, Jack Brown, PharmD3* and Kenneth C Lamp, PharmD2*

1Dept. of Infectious Diseases, M.D. Anderson Cancer Center, Houston, TX
2Cubist, Lexington, MA
3SUNY Buffalo, Buffalo, NY

*signifies non-member of ASH